Modified lipoproteins as biomarkers of atherosclerosis

Area of Science:

• Cardiovascular Medicine
• Biochemistry
• Medical Research

Background:

• Atherosclerosis pathogenesis and effective therapies remain significant medical challenges.
• Current treatments are limited by complex disease mechanisms.
• Lipoproteins, specifically LDL and HDL, are key factors in atherosclerosis.

Purpose of the Study:

• To evaluate low density lipoprotein (LDL) and high density lipoprotein (HDL) roles in atherosclerosis.
• To summarize the established roles of LDL in atherogenesis and HDL's protective functions.
• To critically assess the oxidized LDL hypothesis and propose an alternative model.

Main Methods:

• Literature review and synthesis of existing research on LDL and HDL.
• Analysis of current therapeutic strategies and diagnostic markers for atherosclerosis.
• Evaluation of evidence supporting HDL's protective effects and dysfunction consequences.

Main Results:

• The review summarizes the traditional understanding of LDL's pro-atherogenic and HDL's anti-atherogenic roles.
• Evidence for HDL's protective effects and the impact of HDL dysfunction is discussed.
• The central role of oxidized LDL is questioned, with an alternative proposed.

Conclusions:

• The widely accepted role of oxidized LDL in atherosclerosis may be an oversimplification.
• Multiple modifications of LDL, not solely oxidation, likely contribute to its pro-atherogenic properties.
• Further research into diverse LDL modification pathways is crucial for developing novel therapies.